A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations

M. Ritelli, S. Morlino, E. Giacopuzzi, L. Bernardini, B. Torres, G. Santoro, V. Ravasio, N. Chiarelli, D. D'Angelantonio, A. Novelli, P. Grammatico, M. Colombi, M. Castori

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Deletions encompassing TAK1-binding protein 2 (TAB2) associated with isolated and syndromic congenital heart defects. Rare missense variants are found in patients with a similar phenotype as well as in a single individual with frontometaphyseal dysplasia. We describe a family and an additional sporadic patient with polyvalvular heart disease, generalized joint hypermobility and related musculoskeletal complications, soft, velvety and hyperextensible skin, short limbs, hearing impairment, and facial dysmorphism. In the first family, whole-exome sequencing (WES) disclosed the novel TAB2 c.1398dup (p.Thr467Tyrfs*6) variant that eliminates the C-terminal zinc finger domain essential for activation of TAK1 (TGFβ-activated kinase 1)-dependent signaling pathways. The sporadic case carryed a ~2 Mb de novo deletion including 28 genes also comprising TAB2. This study reveal an association between TAB2 mutations and a phenotype resembling Ehlers-Danlos syndrome with severe polyvalvular heart disease and subtle facial dysmorphism. Our findings support the existence of a wider spectrum of clinical phenotypes associated with TAB2 perturbations and emphasize the role of TAK1 signaling network in human development.

Original languageEnglish
Pages (from-to)126-133
Number of pages8
JournalClinical Genetics
Volume93
Issue number1
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Connective Tissue
Carrier Proteins
Mutation
Phosphotransferases
Phenotype
Heart Diseases
Exome
Ehlers-Danlos Syndrome
Joint Instability
Congenital Heart Defects
Zinc Fingers
Human Development
Hearing Loss
Extremities
Skin
Genes

Keywords

  • Ehlers-Danlos syndrome
  • FLNA
  • polyvalvular heart disease
  • TAB2
  • TAK1
  • valvular dystrophy

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations. / Ritelli, M.; Morlino, S.; Giacopuzzi, E.; Bernardini, L.; Torres, B.; Santoro, G.; Ravasio, V.; Chiarelli, N.; D'Angelantonio, D.; Novelli, A.; Grammatico, P.; Colombi, M.; Castori, M.

In: Clinical Genetics, Vol. 93, No. 1, 01.01.2018, p. 126-133.

Research output: Contribution to journalArticle

Ritelli, M, Morlino, S, Giacopuzzi, E, Bernardini, L, Torres, B, Santoro, G, Ravasio, V, Chiarelli, N, D'Angelantonio, D, Novelli, A, Grammatico, P, Colombi, M & Castori, M 2018, 'A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations', Clinical Genetics, vol. 93, no. 1, pp. 126-133. https://doi.org/10.1111/cge.13032
Ritelli, M. ; Morlino, S. ; Giacopuzzi, E. ; Bernardini, L. ; Torres, B. ; Santoro, G. ; Ravasio, V. ; Chiarelli, N. ; D'Angelantonio, D. ; Novelli, A. ; Grammatico, P. ; Colombi, M. ; Castori, M. / A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations. In: Clinical Genetics. 2018 ; Vol. 93, No. 1. pp. 126-133.
@article{da2e9070b1604c67a4e3b230a9b3100f,
title = "A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations",
abstract = "Deletions encompassing TAK1-binding protein 2 (TAB2) associated with isolated and syndromic congenital heart defects. Rare missense variants are found in patients with a similar phenotype as well as in a single individual with frontometaphyseal dysplasia. We describe a family and an additional sporadic patient with polyvalvular heart disease, generalized joint hypermobility and related musculoskeletal complications, soft, velvety and hyperextensible skin, short limbs, hearing impairment, and facial dysmorphism. In the first family, whole-exome sequencing (WES) disclosed the novel TAB2 c.1398dup (p.Thr467Tyrfs*6) variant that eliminates the C-terminal zinc finger domain essential for activation of TAK1 (TGFβ-activated kinase 1)-dependent signaling pathways. The sporadic case carryed a ~2 Mb de novo deletion including 28 genes also comprising TAB2. This study reveal an association between TAB2 mutations and a phenotype resembling Ehlers-Danlos syndrome with severe polyvalvular heart disease and subtle facial dysmorphism. Our findings support the existence of a wider spectrum of clinical phenotypes associated with TAB2 perturbations and emphasize the role of TAK1 signaling network in human development.",
keywords = "Ehlers-Danlos syndrome, FLNA, polyvalvular heart disease, TAB2, TAK1, valvular dystrophy",
author = "M. Ritelli and S. Morlino and E. Giacopuzzi and L. Bernardini and B. Torres and G. Santoro and V. Ravasio and N. Chiarelli and D. D'Angelantonio and A. Novelli and P. Grammatico and M. Colombi and M. Castori",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/cge.13032",
language = "English",
volume = "93",
pages = "126--133",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations

AU - Ritelli, M.

AU - Morlino, S.

AU - Giacopuzzi, E.

AU - Bernardini, L.

AU - Torres, B.

AU - Santoro, G.

AU - Ravasio, V.

AU - Chiarelli, N.

AU - D'Angelantonio, D.

AU - Novelli, A.

AU - Grammatico, P.

AU - Colombi, M.

AU - Castori, M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Deletions encompassing TAK1-binding protein 2 (TAB2) associated with isolated and syndromic congenital heart defects. Rare missense variants are found in patients with a similar phenotype as well as in a single individual with frontometaphyseal dysplasia. We describe a family and an additional sporadic patient with polyvalvular heart disease, generalized joint hypermobility and related musculoskeletal complications, soft, velvety and hyperextensible skin, short limbs, hearing impairment, and facial dysmorphism. In the first family, whole-exome sequencing (WES) disclosed the novel TAB2 c.1398dup (p.Thr467Tyrfs*6) variant that eliminates the C-terminal zinc finger domain essential for activation of TAK1 (TGFβ-activated kinase 1)-dependent signaling pathways. The sporadic case carryed a ~2 Mb de novo deletion including 28 genes also comprising TAB2. This study reveal an association between TAB2 mutations and a phenotype resembling Ehlers-Danlos syndrome with severe polyvalvular heart disease and subtle facial dysmorphism. Our findings support the existence of a wider spectrum of clinical phenotypes associated with TAB2 perturbations and emphasize the role of TAK1 signaling network in human development.

AB - Deletions encompassing TAK1-binding protein 2 (TAB2) associated with isolated and syndromic congenital heart defects. Rare missense variants are found in patients with a similar phenotype as well as in a single individual with frontometaphyseal dysplasia. We describe a family and an additional sporadic patient with polyvalvular heart disease, generalized joint hypermobility and related musculoskeletal complications, soft, velvety and hyperextensible skin, short limbs, hearing impairment, and facial dysmorphism. In the first family, whole-exome sequencing (WES) disclosed the novel TAB2 c.1398dup (p.Thr467Tyrfs*6) variant that eliminates the C-terminal zinc finger domain essential for activation of TAK1 (TGFβ-activated kinase 1)-dependent signaling pathways. The sporadic case carryed a ~2 Mb de novo deletion including 28 genes also comprising TAB2. This study reveal an association between TAB2 mutations and a phenotype resembling Ehlers-Danlos syndrome with severe polyvalvular heart disease and subtle facial dysmorphism. Our findings support the existence of a wider spectrum of clinical phenotypes associated with TAB2 perturbations and emphasize the role of TAK1 signaling network in human development.

KW - Ehlers-Danlos syndrome

KW - FLNA

KW - polyvalvular heart disease

KW - TAB2

KW - TAK1

KW - valvular dystrophy

UR - http://www.scopus.com/inward/record.url?scp=85027706832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027706832&partnerID=8YFLogxK

U2 - 10.1111/cge.13032

DO - 10.1111/cge.13032

M3 - Article

AN - SCOPUS:85027706832

VL - 93

SP - 126

EP - 133

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -